Great points. The market may be reacting negatively, but we need to wait and see how much money is raised. If CYDY can raise enough to cover 18 months of costs, they may get us to a point where 1. Revenues are coming in and 2. We know if leronlimab works for cancer and possibly multiple cancer indications.